date,title,source
Oct-26-18,Karyopharm Therapeutics Announces Management Change,GlobeNewswire
Oct-29-18,Karyopharm Therapeutics Announces Closing of Additional $22.5 Million of 3.00% Convertible Senior Notes Due 2025 Pursuant to Exercise in Full of Initial Purchasers Option,GlobeNewswire
